Personalis Inc (PSNL)

Jun 06, 2026

Why Personalis Stock Is Rising: Medicare Covers Lung Cancer MRD Test - Stocktwits

Jun 06, 2026

Jun 05, 2026

Personalis (NASDAQ: PSNL) CFO sells 40,000 shares under 10b5-1 plan - Stock Titan

Jun 05, 2026

Jun 05, 2026

Personalis CFO Aaron Tachibana sells $480,400 in company stock - Investing.com

Jun 05, 2026

Jun 04, 2026

Aaron L. Tachibana (PSNL) exercises 40,000 options; prior 38,799 10b5-1 sale - Stock Titan

Jun 04, 2026

Jun 04, 2026

Personalis CEO Sells 100,000 Company Shares Worth $1.1 Million. What Does That Mean for Investors? - Yahoo Finance

Jun 04, 2026

Jun 02, 2026

Personalis Data Highlights Early Cancer Recurrence Detection - Clinical Lab Products

Jun 02, 2026

Jun 02, 2026

Personalis Highlights Early Colorectal Cancer Recurrence Detection and Ultrasensitive MRD Performance Across a Broad Set of Tumor Types at ASCO 2026 - BioSpace

Jun 02, 2026

Jun 01, 2026

Assessing Personalis (PSNL) Valuation After Its Strong Recent Share Price Momentum - Yahoo Finance

Jun 01, 2026

Jun 01, 2026

Personalis Insider Sold Shares Worth $449,292, According to a Recent SEC Filing - marketscreener.com

Jun 01, 2026

May 29, 2026

Personalis CEO Christopher M. Hall sells $1.1m in stock By Investing.com - Investing.com India

May 29, 2026

May 29, 2026

Personalis CEO Christopher M. Hall sells $1.1m in stock - Investing.com

May 29, 2026

May 29, 2026

Personalis CFO and COO Aaron Tachibana sells $449,292 in stock By Investing.com - Investing.com Australia

May 29, 2026

May 29, 2026

Personalis CFO and COO Aaron Tachibana sells $449,292 in stock - Investing.com

May 29, 2026

May 29, 2026

Personalis (NASDAQ: PSNL) CEO sells 100K shares after exercising options - Stock Titan

May 29, 2026

May 29, 2026

Personalis (PSNL) CFO sells shares via pre-set Rule 10b5-1 plan - Stock Titan

May 29, 2026

May 29, 2026

Personalis (PSNL) Is Up 34.5% After CMS Expands NeXT Personal MRD Test Medicare Coverage - simplywall.st

May 29, 2026

May 29, 2026

Personalis stock hits 52-week high at $11.51 By Investing.com - Investing.com Australia

May 29, 2026

May 29, 2026

[144] Personalis, Inc. SEC Filing - Stock Titan

May 29, 2026

May 29, 2026

Personalis, Inc. Hits Day High with 15.7% Surge in Stock Price - Markets Mojo

May 29, 2026

May 28, 2026

Personalis: Initiating Coverage Of Cancer Testing Biotech With A Buy Rating (NASDAQ:PSNL) - Seeking Alpha

May 28, 2026

May 28, 2026

ETFs Investing in Personalis, Inc. Stocks - TradingView

May 28, 2026

May 28, 2026

Personalis gains after fourth Medicare coverage win for NeXT Personal - MSN

May 28, 2026

May 26, 2026

Personalis to Highlight Breadth of NeXT Personal® Ultra-Sensitive ctDNA Data at ASCO 2026 Annual Meeting, Including Podium Presentation from TRACERx Consortium - BioSpace

May 26, 2026

May 25, 2026

Personalis Inc. (PSNL) Rallies 2.67% as Volume Picks Up – Key Levels in SightFair Value Gap - thelegaladvocate.com

May 25, 2026

May 22, 2026

Personalis Inc. (PSNL) Surges 4.5% as Stock Tests Key Resistance Near $9.05Overnight Profile - thelegaladvocate.com

May 22, 2026

May 21, 2026

Craig-Hallum Maintains Personalis(PSNL.US) With Buy Rating - Moomoo

May 21, 2026

May 21, 2026

Personalis outlines 2026 clinical volume target of 43,000 to 45,000 tests while reaffirming $78M to $80M revenue guidance - MSN

May 21, 2026

May 20, 2026

Personalis NeXT Disease Test Approved for Expanded Coverage by Medicare, Medicaid - Moomoo

May 20, 2026

May 20, 2026

Lake Street Maintains Personalis(PSNL.US) With Buy Rating, Maintains Target Price $11 - Moomoo

May 20, 2026

May 20, 2026

Medicare Expands Coverage for Personalis NeXT Personal Test - TipRanks

May 20, 2026

May 20, 2026

US agency broadens coverage of Personalis breast cancer test - MSN

May 20, 2026

May 20, 2026

Expanded Medicare covers Personalis (NASDAQ: PSNL) NeXT Personal cancer test - Stock Titan

May 20, 2026

May 20, 2026

Personalis gains expanded Medicare coverage for breast cancer test By Investing.com - Investing.com Nigeria

May 20, 2026

May 20, 2026

US Agency Broadens Coverage Of Personalis Breast Cancer Test - Benzinga

May 20, 2026

May 20, 2026

Personalis Shares Rise After NeXT Disease Test Approved for Expanded Coverage by Medicare, Medicaid - marketscreener.com

May 20, 2026

May 20, 2026

Personalis (PSNL) Shares Climb on Expanded Medicare Coverage for NeXT Personal Test - GuruFocus

May 20, 2026

May 20, 2026

Personalis (PSNL) Expands Medicare Coverage for NeXT Personal Te - GuruFocus

May 20, 2026

May 20, 2026

Personalis gets expanded Medicare coverage for NeXT Personal - Seeking Alpha

May 20, 2026

May 20, 2026

Personalis secures fourth Medicare coverage decision for Next Personal, expanding breast cancer coverage to pre-surgical treatment monitoring - marketscreener.com

May 20, 2026

May 20, 2026

Personalis gains expanded Medicare coverage for breast cancer test - Investing.com

May 20, 2026

May 20, 2026

Personalis Secures Fourth Medicare Coverage Decision for NeXT Personal®, Expanding Breast Cancer Coverage to Pre-Surgical Treatment Monitoring - Business Wire

May 20, 2026

May 18, 2026

Personalis rises as Medicare coverage for NeXT Personal test expands - MSN

May 18, 2026